Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Urology Practice
|
March 31, 2026
Implementation of a Telehealth-Based Rapid Access Program for the Evaluation of Men Referred for Elevated PSA
Zachary S Feuer, Heather Schultz, Fahad S Mohammed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 13, 2016
Impact of Reported Beta-Lactam Allergy on Inpatient Outcomes: A Multicenter Prospective Cohort Study
Derek R MacFadden, Anthony LaDelfa, Jessica Leen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
August 6, 2015
Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory
Joshua M Stolker, Michael J Lim, David M Shavelle, et al.
Archives of Internal Medicine
|
February 11, 2004
Paroxetine-induced hyponatremia in older adults: a 12-week prospective study
Tanya J Fabian, Janet A Amico, Patricia D Kroboth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Point-of-Care β-Lactam Allergy Skin Testing by Antimicrobial Stewardship Programs: A Pragmatic Multicenter Prospective Evaluation
Jerome A Leis, Lesley Palmay, Grace Ho, et al.
Transplantation and Cellular Therapy
|
May 21, 2023
Survival Outcomes for Patients with Relapsed/ Refractory Aggressive B Cell Lymphomas Following Receipt of High-Dose Chemotherapy/Autologous Stem Transplantation and/or Chimeric Antigen Receptor-Modified T Cells
Daniel J Landsburg, Sunita D Nasta, Jakub Svoboda, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 20, 2022
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting
Sunita D Nasta, Mitchell E Hughes, Esin C Namoglu, et al.
Future Oncology (London, England)
|
May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma
Daanish Hoda, Robert Richards, Edward A Faber, et al.
Transplantation and Cellular Therapy
|
March 17, 2024
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma
Elise A Chong, Emeline R Chong, Dylan Therwhanger, et al.
Journal of Hematology & Oncology
|
April 21, 2024
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel
Guido Ghilardi, Luca Paruzzo, Vrutti Patel, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Urology Practice
|
March 31, 2026
Implementation of a Telehealth-Based Rapid Access Program for the Evaluation of Men Referred for Elevated PSA
Zachary S Feuer, Heather Schultz, Fahad S Mohammed, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 13, 2016
Impact of Reported Beta-Lactam Allergy on Inpatient Outcomes: A Multicenter Prospective Cohort Study
Derek R MacFadden, Anthony LaDelfa, Jessica Leen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
August 6, 2015
Pooled comparison of regadenoson versus adenosine for measuring fractional flow reserve and coronary flow in the catheterization laboratory
Joshua M Stolker, Michael J Lim, David M Shavelle, et al.
Archives of Internal Medicine
|
February 11, 2004
Paroxetine-induced hyponatremia in older adults: a 12-week prospective study
Tanya J Fabian, Janet A Amico, Patricia D Kroboth, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 3, 2017
Point-of-Care β-Lactam Allergy Skin Testing by Antimicrobial Stewardship Programs: A Pragmatic Multicenter Prospective Evaluation
Jerome A Leis, Lesley Palmay, Grace Ho, et al.
Transplantation and Cellular Therapy
|
May 21, 2023
Survival Outcomes for Patients with Relapsed/ Refractory Aggressive B Cell Lymphomas Following Receipt of High-Dose Chemotherapy/Autologous Stem Transplantation and/or Chimeric Antigen Receptor-Modified T Cells
Daniel J Landsburg, Sunita D Nasta, Jakub Svoboda, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
May 20, 2022
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting
Sunita D Nasta, Mitchell E Hughes, Esin C Namoglu, et al.
Future Oncology (London, England)
|
May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma
Daanish Hoda, Robert Richards, Edward A Faber, et al.
Transplantation and Cellular Therapy
|
March 17, 2024
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma
Elise A Chong, Emeline R Chong, Dylan Therwhanger, et al.
Journal of Hematology & Oncology
|
April 21, 2024
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel
Guido Ghilardi, Luca Paruzzo, Vrutti Patel, et al.
Page
of 3